MiNK Therapeutics Overview
MiNK Therapeutics (INKT) has a PEG ratio of 19.26, above the Healthcare sector average of 3.22.
Get informed when a big investor buys or sells
+ Follow19.26
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
As of the most recent data, INKT shows a PEG ratio of 19.26. That is above the Healthcare sector average of 3.22. Scroll down for historical charts and peer comparison views.
The Healthcare sector average PEG ratio is about 3.22. MiNK Therapeutics is at 19.26, which is higher that average. That is roughly 497.6% above the sector mean. Use the comparison chart on this page to see how INKT stacks up against individual peers as well.
Investors watch INKT's PEG ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. MiNK Therapeutics's latest reading is 19.26. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this peg ratio page, Stockcircle has MiNK Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect PEG ratio (currently 19.26) with ownership activity and broader fundamentals.
The Healthcare average PEG ratio is about 3.22, while INKT is at 19.26. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
